Log in to save to my catalogue
Log in to save to my catalogue

Viron Therapeutics Inc.; Viron reports positive Phase II data in Acute Coronary Syndromes ACS patien...

| Ask | Become a Library member

Viron Therapeutics Inc.; Viron reports positive Phase II data in Acute Coronary Syndromes ACS patien...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_212931823

Viron Therapeutics Inc.; Viron reports positive Phase II data in Acute Coronary Syndromes ACS patients

About this item

Full title

Viron Therapeutics Inc.; Viron reports positive Phase II data in Acute Coronary Syndromes ACS patients

Publisher

Atlanta: NewsRx

Journal title

Virus Weekly, 2009, p.202

Language

English

Formats

Newsletter articles

Publication information

Publisher

Atlanta: NewsRx

Subjects

Subjects and topics

More information

Scope and Contents

Contents

2009 DEC 1 - ( NewsRx.com) -- Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus. The results were p...

Alternative Titles

Full title

Viron Therapeutics Inc.; Viron reports positive Phase II data in Acute Coronary Syndromes ACS patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_212931823

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_212931823

Other Identifiers

ISSN

1531-6424

E-ISSN

1532-4710

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections